Clinical trial
A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)
NCT02461069 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)
- Lead sponsor
- University Hospital Muenster
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 6, 2015
- Completion date
- May 7, 2018
- Enrollment
- 67 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.